[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@investseekers Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1477615559252586500.png) @investseekers Investseekers

Investseekers posts on X about $nvo, stocks, bank, target the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

### Engagements: XXXXXX [#](/creator/twitter::1477615559252586500/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1477615559252586500/c:line/m:interactions.svg)

- X Week XXXXXX -XX%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +195%
- X Year XXXXXXXXX +2,112%

### Mentions: XX [#](/creator/twitter::1477615559252586500/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1477615559252586500/c:line/m:posts_active.svg)

- X Week XXX -XX%
- X Month XXX +11%
- X Months XXXXX +108%
- X Year XXXXX +515%

### Followers: XXXXX [#](/creator/twitter::1477615559252586500/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1477615559252586500/c:line/m:followers.svg)

- X Week XXXXX +0.95%
- X Month XXXXX +10%
- X Months XXXXX +125%
- X Year XXXXX +751%

### CreatorRank: XXXXXXX [#](/creator/twitter::1477615559252586500/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1477615559252586500/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXXX% [currencies](/list/currencies)  #2231 [countries](/list/countries)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [technology brands](/list/technology-brands)  XXXX% [travel destinations](/list/travel-destinations)  XXXX% [social networks](/list/social-networks)  XXXX% [exchanges](/list/exchanges)  XXXX%

**Social topic influence**
[$nvo](/topic/$nvo) #7, [stocks](/topic/stocks) #1483, [bank](/topic/bank) #1730, [target](/topic/target) #1050, [strong](/topic/strong) #2674, [$lly](/topic/$lly) #49, [denmark](/topic/denmark) #605, [nvo](/topic/nvo) 4.03%, [closed](/topic/closed) #1212, [products](/topic/products) XXXX%

**Top accounts mentioned or mentioned by**
[@1mak_96](/creator/undefined) [@dividendtsar](/creator/undefined) [@preseidentmusk](/creator/undefined) [@researchpulse1](/creator/undefined) [@misswolf72](/creator/undefined) [@tonymacarroni91](/creator/undefined) [@woodywgxonfire](/creator/undefined) [@seep2p](/creator/undefined) [@vanhove_pieter](/creator/undefined) [@bradocapital](/creator/undefined) [@europeandgi](/creator/undefined) [@vanhovepieter](/creator/undefined) [@stockmktnewz](/creator/undefined) [@joecarlsonshow](/creator/undefined) [@gozzy2000](/creator/undefined) [@dalioinvest](/creator/undefined) [@dividendbelievr](/creator/undefined) [@humlerun](/creator/undefined) [@rockbolig](/creator/undefined) [@grok](/creator/undefined)

**Top assets mentioned**
[Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly) [TransDigm Group, Inc. (TDG)](/topic/$tdg) [Alibaba Group (BABA)](/topic/$baba) [HSBC Holdings PLC (HSBC)](/topic/$hsbc) [Momo (MOMO)](/topic/$momo) [Watsco, Inc. (WSO)](/topic/$wso) [Neumora Therapeutics, Inc. Common Stock (NMRA)](/topic/$nmra) [Expeditors International of Wshngtn Inc (EXPD)](/topic/$expd) [Copart, Inc. (CPRT)](/topic/$cprt) [Palantir (PLTR)](/topic/$pltr) [Pfizer, Inc. (PFE)](/topic/$pfe) [Unifi Protocol DAO (UNFI)](/topic/$unfi) [Ulta Beauty Inc (ULTA)](/topic/$ulta) [JinPeng (JIN)](/topic/$jin) [Morgan Stanley (MS)](/topic/morgan-stanley)
### Top Social Posts
Top posts by engagements in the last XX hours

"I guess everyone here knows I own $NVO but with the Danish #StockMarket underperforming this year many other high-quality Danish companies are suddenly trading at much more attractive valuations. One of them is Coloplast and Im considering buying soon. Its not well-known outside Denmark but its a global leader in intimate healthcare with products patients rely on daily and often stay with for decades creating an incredibly durable customer base. I just updated my full Coloplast analysis you can read it here:"  
[X Link](https://x.com/investseekers/status/1995166809020891314)  2025-11-30T16:23Z 4879 followers, 10.2K engagements


"Investor Lau Svenssen says $NVO is one of three stocks he plans to bet on next year despite a tough 2025 for shareholders. He expects the stock to climb to 450500 DKK by end-2026 a 4258% gain from current levels. Lau Svenssen believes Novo is getting control of copycat pressure and sees upside from the upcoming obesity pill and progress on CagriSema. Risks remain but he thinks Novo has found the bottom and is ready to rebound. Link to article (in Danish): #StocksToWatch #Investing"  
[X Link](https://x.com/investseekers/status/1995412301566943346)  2025-12-01T08:39Z 4879 followers, 9345 engagements


"An analysis by Fifty Or Nothing breaks down what revenues $LLY and $NVO would need to justify their current market caps. To justify $948B Eli Lilly would need revenue to grow from $59B to $168B in X years (23% CAGR). For Novo Nordisk today's valuation implies a -XXX% annual revenue decline over X years even though the company guides for X% growth. Link to analysis: #StocksToWatch #Investing"  
[X Link](https://x.com/investseekers/status/1997658808068284824)  2025-12-07T13:25Z 4879 followers, 13.7K engagements


"Structure Therapeutics just reported positive Phase X results for its once-daily oral weight-loss pill Aleniglipron which may explain the drop in $NVO today. After XX weeks: XXX mg dose: XXXX% placebo-adjusted weight loss XXX mg dose: up to XXXX% placebo-adjusted weight loss Discontinuation due to side effects: XXXX% The company says the higher-dose results may be the best in class so far for oral small-molecule GLP-1s and provides strong justification to move into Phase X. Structure Therapeutics plans to start Phase X trials in mid-2026. #StocksToWatch #InvestingTips"  
[X Link](https://x.com/investseekers/status/1998046012997308694)  2025-12-08T15:04Z 4879 followers, 4100 engagements


"$MOMO reports earnings on Wednesday. Often called the Chinese Tinder the stock is still trading below book value. Full analysis here: #StocksToWatch #invest"  
[X Link](https://x.com/investseekers/status/1998128826384085124)  2025-12-08T20:33Z 4879 followers, XXX engagements


"$RI.PA is down XX% from 2023 highs as health trends GLP-1 drugs & new rivals weigh on alcohol stocks. #WarrenBuffett is buying into the sector. I just updated my analysis: #stocks #investing #alcohol"  
[X Link](https://x.com/investseekers/status/1967308997079212538)  2025-09-14T19:26Z 4872 followers, 1697 engagements


"$WSO reports earnings next week. Its total shareholder return ranks among the top XX of all U.S. public companies over the past XX years and it is one of only XX companies to deliver more than XX% annualized returns. Yet the shares are down more than XX% in 2025. Read my full analysis here: #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1982496949203800505)  2025-10-26T17:18Z 4876 followers, XXX engagements


"$NMRA plans to begin human trials in early 2026 for an oral obesity drug called NMRA-215. In mice the drug led to up to XX% weight loss on its own and XX% when combined with $NVO 's semaglutide (Wegovy). #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1982882237411381530)  2025-10-27T18:49Z 4873 followers, 2014 engagements


"Uncertainty around $NVO is massive ahead of Wednesdays earnings report. After a CEO change multiple guidance cuts mass layoffs and a near-total board overhaul investors fear another downgrade may be coming. Sydbank Jyske Bank and Danske Bank all point to weak prescription trends for Novos key drugs and see a risk that the company could lower the top end of its guidance again. Adding to the pressure are U.S. pricing concerns. The Trump administration is pushing for a most favored nation program that could force drug prices down and Medicare price negotiations for Ozempic Rybelsus and Wegovy"  
[X Link](https://x.com/investseekers/status/1984640574205440031)  2025-11-01T15:16Z 4872 followers, 4363 engagements


"$EXPD reports earnings next week. Expeditors International of Washington is a global logistics company that moves goods by air ocean and ground while offering customs and supply chain services. Its asset-light model owning no planes or ships keeps it flexible and cost-efficient through economic cycles. Full analysis here: #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1984937907904229691)  2025-11-02T10:57Z 4875 followers, XXX engagements


"$TDG reports earnings Thursday. TransDigm is a leader in aerospace supplying proprietary and mission-critical components found in nearly every commercial and military aircraft. With about XX% of revenue coming from proprietary parts and XX% from sole-sourced components its pricing power is exceptional. Full analysis: #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1986072509746233569)  2025-11-05T14:06Z 4876 followers, 1192 engagements


"Jyske Bank analyst Henrik Hallengreen Laustsen calls the Novo NordiskWhite House deal a win-win: Novo gets access to far more patients while Trump can claim he lowered drug prices. He says the agreement is positive for $NVO because it brings stability and reduces long-term uncertainty in the U.S. market. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1986720025797923259)  2025-11-07T08:59Z 4871 followers, 2681 engagements


"Danske Bank just nudged its price target on $NVO slightly lower to XXX DKK from XXX while maintaining its Buy rating. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1989290589041398128)  2025-11-14T11:13Z 4872 followers, 1412 engagements


"The Danish C25 index fell XXX% on Monday. rsted led the gains with a rise of XXX% followed by Bavarian Nordic at XXX% and Zealand Pharma at 2.1%. $NVO was up XXX percent after announcing lower U.S. pricing for Ozempic and Wegovy. #stocks #investing #Denmark"  
[X Link](https://x.com/investseekers/status/1990472627643707531)  2025-11-17T17:30Z 4873 followers, 1204 engagements


"Novo Holdings the controlling shareholder of $NVO is selling its entire XXX% stake in medical device maker Convatec. It plans to sell about XXX million shares worth roughly XXX million pounds based on Mondays closing price. The shares will be sold quickly to institutional investors and the final price will be set shortly. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1990534284151554107)  2025-11-17T21:35Z 4871 followers, 2540 engagements


"Danish GDP just surprised with a XXX% jump in Q3 and the driver is clear: $NVO. Despite the C25 being one of the worst performing stock markets in the world in 2025 Denmarks economy is booming again thanks to Novos massive pharma exports. As Danske Banks chief economist put it: Denmark is a normal European economy just with Novo Nordisk on top. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1991510620097700000)  2025-11-20T14:15Z 4872 followers, 2860 engagements


"$CPRT reports earnings tonight. Copart runs one of the worlds largest online vehicle auction platforms connecting insurance companies dealers rental fleets and buyers across the globe. When a car is damaged or totaled it often ends up being sold through Copart. Its a business I would love to own. Full analysis here: #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1991608487982358916)  2025-11-20T20:44Z 4873 followers, 1420 engagements


"Jyske Bank analyst Henrik Hallengreen says some investors bought $NVO hoping the Evoke data would be a fresh start but disappointment has brought back negative sentiment reflected in todays drop. He still sees semaglutides weight-loss potential unchanged. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1992949575800250674)  2025-11-24T13:33Z 4871 followers, 2589 engagements


"I added more $NVO today its still my second-largest position after Prosus. If the 3-day rule ends up applying to Novo Nordisk Ill probably be buying again tomorrow and Wednesday too. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1993041051464929589)  2025-11-24T19:36Z 4873 followers, 5161 engagements


"$BABA reports earnings Tuesday and its my third-largest position after $NVO and Prosus. #Alibaba is a dominant force in China with an ecosystem that spans e-commerce cloud computing logistics and digital services. Taobao and Tmall lead online retail Alibaba Cloud is a major player and the company is doubling down on AI global expansion and new monetization tools. Why I own it: #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1993070369930887350)  2025-11-24T21:33Z 4873 followers, 1300 engagements


"Handelsbanken says the markets expectations for $NVO are far too high and predicts 2026 will be a wake-up call for the company. The bank downgraded Novo to Sell (from Hold) and cut its price target to DKK XXX from XXX. Analysts argue its unrealistic to expect Novo to grow twice as fast as the pharma industry (7% annually from 20252030). They cite ongoing price pressure rising competition and reluctance from reimbursement systems to pay for weight-loss drugs. Handelsbanken forecasts: Gross margin falling X percentage points in 2026 Revenue down X% Operating profit down X% (FX-adjusted)"  
[X Link](https://x.com/investseekers/status/1993956174366941395)  2025-11-27T08:12Z 4872 followers, 14.3K engagements


"Ahead of $NVO s extraordinary general meeting earlier this month tensions were high as Lars Rebien Srensen moved to replace most of the board and take over as chairman. According to Brsen the vote passed mainly because the Novo Nordisk Foundation with XX% of the voting powerthrough its A-shares backed the change. Without the foundations votes XXXX% of shareholders would have voted against Lars Rebien Sorensen as chairman and just XXXX% in favor. #Stocks #Invest"  
[X Link](https://x.com/investseekers/status/1994370715152224387)  2025-11-28T11:40Z 4872 followers, 3585 engagements


"Earlier I shared Jyske Banks U.S. NRx data for $NVO which shows new prescriptions from first-time starts and now @ResearchPulse1 has the TRx numbers which include all prescriptions including refills:"  
[X Link](https://x.com/investseekers/status/1994434675595477230)  2025-11-28T15:54Z 4871 followers, 4003 engagements


"I just updated my full analysis of $TDG and its the longest deep dive I have ever written. Around XX% of TDGs sales come from components it uniquely designs and owns and roughly 7580% of revenue comes from parts where TransDigm is the only approved supplier. These are mission-critical products with long lifecycles and strong pricing power. Its a company I would love to add to the portfolio one day. Read the full analysis here: #Stocks #Invest"  
[X Link](https://x.com/investseekers/status/1994505199608623138)  2025-11-28T20:34Z 4872 followers, 1742 engagements


"@StockMKTNewz Just for context: $NVO s Rare Diseases segment which is only X% of its business generated more revenue in 2024 than all of $PLTR. Novo Nordisk sits at around a $219B market cap while Palantir is about $401B"  
[X Link](https://x.com/investseekers/status/1994886854072832148)  2025-11-29T21:51Z 4872 followers, 2625 engagements


"Motley Fool just broke down why $NVO hit a 4-year low on Monday. Nothing really new if you follow this account but still a good summary Novo Nordisk dropped below $XX after its Phase X Alzheimers trial for semaglutide failed to show any benefit a lottery ticket that didnt pay off. It caps a rough 2025: Losing GLP-1 share to $LLY Metsera bidding war lost to $PFE Multiple guidance cuts Stock now down XX% YTD Still the GLP-1 race is far from over and obesity remains one of the biggest markets in healthcare. Link to article: #Stocks #Investing"  
[X Link](https://x.com/investseekers/status/1995093436832055513)  2025-11-30T11:31Z 4872 followers, 5685 engagements


"$UNFI reports earnings on Tuesday. United Natural Foods is one of the largest food distributors in North America connecting thousands of producers with retailers ranging from small local stores to major players like Whole Foods. Its scale national network and focus on natural & sustainable foods make it an important company in the grocery supply chain. Full analysis: #Stocks #Investing"  
[X Link](https://x.com/investseekers/status/1995591985592230099)  2025-12-01T20:33Z 4875 followers, 1001 engagements


"The U.S. and U.K. just struck a major drug-pricing deal one that could benefit all global pharma players including $NVO and $LLY. Britain will raise the net price it pays for new patented medicines by XX% and overhaul its tax system to ease the burden on drugmakers in exchange for zero U.S. tariffs on U.K. pharmaceutical exports for at least three years. The deal marks a key win for Trumps push to get other countries to pay more for medicines instead of relying on U.S. patients to subsidize global prices. Link to article: #Stocks #Investing"  
[X Link](https://x.com/investseekers/status/1995720400056058217)  2025-12-02T05:03Z 4872 followers, 3108 engagements


"$LLY has surged XX% since its strong Q3 report prompting Germanys Berenberg to raise its price target to $XXX (from $830). The stock trades above $1050 so the bank keeps only a Hold rating. Lilly is now a $1T+ company on expectations for its oral weight-loss drug Orforglipron and continued momentum in Zepbound/Mounjaro. Both Lilly and $NVO recently agreed with the Trump administration to cut U.S. cash-pay prices on GLP-1s: 1520% for Lilly and 3060% for Novo per Berenberg. #Stocks #Investing"  
[X Link](https://x.com/investseekers/status/1995804101657977223)  2025-12-02T10:35Z 4873 followers, 2066 engagements


"UBS cuts its price target on $NVO to DKK XXX (from 315) and reiterates its Neutral rating. #Stocks #Investing"  
[X Link](https://x.com/investseekers/status/1996539730171736231)  2025-12-04T11:19Z 4873 followers, 1680 engagements


"$NVO s ADR closed at $XXXXX (+0.9%). Converted to DKK thats XXXXX versus XXXXXX in Copenhagen meaning Novo ended above its Copenhagen close by +0.6%. #StocksInFocus #Investing"  
[X Link](https://x.com/investseekers/status/1996846753308434626)  2025-12-05T07:39Z 4872 followers, 1221 engagements


"J.P. Morgan cuts its price target on $NVO to XXX DKK (from 500) but reiterates its Overweight rating. #stocks #Investing"  
[X Link](https://x.com/investseekers/status/1997977705602494688)  2025-12-08T10:33Z 4879 followers, 7308 engagements


"The Danish C25 index slipped XXX% on Tuesday. Biotech names weighed on the index with Zealand Pharma the biggest decliner of the day. Genmab also fell 2.2%. $NVO finished the session almost flat up 0.07%. #StockMarket #Invest"  
[X Link](https://x.com/investseekers/status/1998443147236618448)  2025-12-09T17:22Z 4879 followers, XXX engagements


"This tweet summarizes what some Danish analysts have said about $NVO s Q3 results: Saxo Bank: Wegovy sales disappointed slightly but Ozempic beat expectations and cost focus is improving. Danske Bank: Growth outlook trimmed but Novo still shows strength in key products. Sydbank: Challenges remain in the US but the stock already reflects very pessimistic scenarios we maintain Buy. Global Health Invest: A minor disappointment; sales X% below expectations. Novo is losing US market share in obesity and GLP-1 so a lower P/E multiple is justified. Artha: Rising competition and copy drugs only"  
[X Link](https://x.com/investseekers/status/1986512911250895215)  2025-11-06T19:16Z 4879 followers, 3735 engagements


"$ULTA reports earnings Thursday. Ulta Beauty is the largest specialty beauty retailer in the U.S. mixing prestige + mass brands salon services and a powerful digital platform. Its loyalty ecosystem and brand partnerships have fueled steady growth and the lipstick effect means beauty often holds up even in downturns. Full analysis here: #Stocks #Investing"  
[X Link](https://x.com/investseekers/status/1996683678764638311)  2025-12-04T20:51Z 4879 followers, XXX engagements


"Commentary from Per Hansen Investment Economist at Nordnet: Most expect FDA approval of $NVO 's Wegovy pill within the coming weeks. Approval could help stabilize sentiment but Per Hansen argues that investors are really waiting for a cocktail of positive signals before believing in a true long-term turnaround. Key points: FDA approval of the Wegovy tablet is widely expected anything less than a clean approval would be a major shock and likely push the stock lower. A big rally on approval alone is unlikely; markets want confirmation not just expectation. What comes next Investors will look"  
[X Link](https://x.com/investseekers/status/1997943857703502292)  2025-12-08T08:18Z 4879 followers, 5057 engagements


"$NVO has now completed its acquisition of Akero Therapeutics. Novo Nordisk paid $54/share in cash (about $4.7B) and will pay another $6/share if Akeros MASH drug EFX gets U.S. approval bringing the total deal to about $5.2B. Akero is now fully owned by Novo and will be delisted from Nasdaq. The deal gives Novo a strong late-stage MASH candidate as part of its expanding pipeline. Link to announcement: #stocks #Investing"  
[X Link](https://x.com/investseekers/status/1998397488340897951)  2025-12-09T14:21Z 4879 followers, 4020 engagements


"HSBC just raised its price target on $NVO by XXXX% from XXX DKK to XXX DKK implying about XX% upside from current levels. The bank keeps its Hold rating but says Novo Nordisks shares may have more room to run. #StocksToWatch #Investing"  
[X Link](https://x.com/investseekers/status/1998639809263206447)  2025-12-10T06:23Z 4879 followers, 3063 engagements


"Lars Hytting (ArthaScope) has picked three stocks he believes can beat the market in 2026 and one of them is $NVO. After a tough year with the stock down XX% he expects Novo Nordisk to rebound seeing potential for a 1015% gain next year. He says the worst is priced in: Were at a point where no news is good news. Key catalysts hes watching: the Wegovy pill launch and upcoming obesity-drug data both of which he expects to deliver. Link to article (in Danish): #StocksToWatch #Investing"  
[X Link](https://x.com/investseekers/status/1998655673035280822)  2025-12-10T07:27Z 4879 followers, 5644 engagements


"Im XX% in cash right now. Besides $NVO what #stocks look interesting at current valuations It doesnt matter which market. Drop some tickers for me to research"  
[X Link](https://x.com/investseekers/status/1982514313181970583)  2025-10-26T18:27Z 4874 followers, 14.7K engagements


"The Danish C25 index closed down X% on Thursday. $NVO ended the day down XXX% while Zealand Pharma was the days winner after investors reacted positively to fresh updates in its Q3 report. At the other end of the index momentum faded for Vestas as the stock fell XXX% today #stocks #investing #Denmark"  
[X Link](https://x.com/investseekers/status/1989029999312064954)  2025-11-13T17:58Z 4873 followers, XXX engagements


"The Danish C25 index closed up XXX% on Thursday its third straight day in the green. $NVO finished XXXX% lower after Handelsbanken downgraded the stock arguing market expectations are too high. At the top of the index was GN Store Nord jumping 5.9%. #StockMarket #Denmark"  
[X Link](https://x.com/investseekers/status/1994096002861576481)  2025-11-27T17:28Z 4876 followers, 1568 engagements


"@joecarlsonshow Prosus $NVO and $BABA"  
[X Link](https://x.com/investseekers/status/1996249607257387192)  2025-12-03T16:06Z 4873 followers, 6327 engagements


"Denmark is examining whether $NVO could be held liable for compensation claims linked to serious Wegovy-related vision injuries but legal experts say Novo will likely avoid paying. A health law scholar notes the company can argue these are development injuries meaning side effects that couldnt have been known when the drug was approved. Whether Novo first became aware of a possible link is key. Two Danish studies in late 2024 suggested a connection and severe vision loss was added as a side effect this October. Novo still maintains there is no proven causal link. The state rarely seeks"  
[X Link](https://x.com/investseekers/status/1996492058823897513)  2025-12-04T08:09Z 4874 followers, 1891 engagements


"$NVO is warning U.S. consumers about counterfeit Ozempic X mg pens after the FDA seized fake units sold outside the authorized supply chain. The contents are still unknown and may pose safety risks. Counterfeits remain a major issue for both Novo Nordisk and $LLY hopefully well see tougher penalties for those distributing them. Link to announcement: #stocks #Investing"  
[X Link](https://x.com/investseekers/status/1997264632029794339)  2025-12-06T11:19Z 4878 followers, 4072 engagements


"I recently wrote about Healthifys partnership with $NVO in India but the companys ambitions are much bigger. Healthify plans to become the leading global patient-support provider for all GLP-1 drugmakers. After signing its first deal with Novo Nordisk India its now seeking partnerships with other pharma companies as the weight-loss market booms. Healthify already serves 45M users and its GLP-1 program is its fastest-growing offering expected to make up over a third of paid subscriptions next year. Link to article: #stocks #Investing"  
[X Link](https://x.com/investseekers/status/1997310559985803599)  2025-12-06T14:22Z 4879 followers, 1669 engagements


"The Danish C25 index slipped XXX% on Monday. Zealand Pharma led the index rising XXX% while $NVO fell XXX% on the day. #stocks #Investing"  
[X Link](https://x.com/investseekers/status/1998094824113852866)  2025-12-08T18:18Z 4874 followers, 1078 engagements


"Jumbo Interactive ( $JIN ) jumps +8% after announcing its entry into the UK prize draw market with the acquisition of Dream Car Giveaways a leading B2C platform offering car cash and lifestyle prizes. The deal worth A$109.9M marks Jumbos biggest step yet in expanding internationally. DCG generated A$118M in TTV and A$17.9M in revenue over the past year and the acquisition is expected to be EPS accretive within XX months. With a 6.5x EBITDA multiple and 2025% EBITDA growth expected the deal looks like a strong strategic move and despite todays jump the shares still look cheap. Read my full"  
[X Link](https://x.com/investseekers/status/1978365223766569230)  2025-10-15T07:40Z 4878 followers, XXX engagements


"Some analysts now see a golden buying opportunity in $NVO. Despite internal turmoil share price declines and fierce competition in the obesity market major financial institutions remain optimistic. Four banks Jyske Bank SEB DNB Carnegie and BNP Paribas all reiterated buy ratings Thursday seeing upside from the current DKK XXX. SEBs analyst Martin Parkhi is the most bullish with a DKK XXX target implying XX% upside. In total XX of XX analysts covering Novo Nordisk rate it a buy with an average target of DKK XXX suggesting a XX% rise over the next year. Nykredit is most optimistic at DKK 700"  
[X Link](https://x.com/investseekers/status/1984008030791270634)  2025-10-30T21:22Z 4878 followers, 6435 engagements


"Danske Bank reiterates its Buy rating on $ZEAL with a price target of DKK XXX citing strong potential in the growing market for MASH (fatty liver disease). The bank highlights: Survodutide developed by partner Boehringer Ingelheim is entering Phase X with results expected in H1 2026. Boehringers heavy investment and more than XX ongoing trials validate Survodutides potential. The global MASH drug market could reach $32B by 2030 led by FGF21 drugs though Survodutide (a GLP-1/glucagon dual agonist) remains well-positioned. Danske Bank adds: A large part of Zealand Pharmas future will be decided"  
[X Link](https://x.com/investseekers/status/1988219028544876942)  2025-11-11T12:15Z 4878 followers, 2654 engagements


"$NVO CEO Mike Doustdar is showing a clear willingness to take bigger strategic risks to win back lost market share. Some analysts welcome the shift Jyske Banks Henrik Hallengreen Laustsen calls the Metsera bidding war an important signal that Novo is no longer being passive. But others are far more critical. BMOs Evan Seigerman says Novo is shooting from the hip comparing the company to a ship that has drifted so far off course that correcting it may be difficult. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1988929081937682500)  2025-11-13T11:17Z 4878 followers, 3421 engagements


"$PROSY bought back another 1120709 shares last week at an average price of XXXXX. Prosus has now repurchased shares every single week since June 2022. It remains my largest position ahead of $NVO. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1990893274370855045)  2025-11-18T21:22Z 4875 followers, 1178 engagements


"Zealand Pharma CEO Adam Steensberg just made some bold comments about the companys potential obesity drug petrelentide. Speaking at a health conference in London he said petrelentide could be developed into a monthly product and may match or even exceed treatments from $NVO and $LLY. Were likely 510x more potent with similar tolerability Adam Steensberg said comparing it to Lillys elorantide. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1991567845440794786)  2025-11-20T18:02Z 4875 followers, 1461 engagements


"The Danish C25 index climbed XXXX% on Wednesday. The biggest gainer was $NVO closing up XXXX% followed by Zealand Pharma (+3.07%) and $GMAB (+2.50%). The weakest performer was Rockwool. Despite slightly beating expectations on both revenue and profit in its Q3 results the stock still fell XXXX% on the day. #StockMarket #investing"  
[X Link](https://x.com/investseekers/status/1993720776185287082)  2025-11-26T16:37Z 4875 followers, 1313 engagements


"Analysts are split on $NVO. Novo Nordisk now carries an average Hold rating from XX analysts: X sell XX hold X buy X strong buy Avg. price target on the US ADR: $XXXXX Views are all over the place Morgan Stanley cut to underweight ($47 PT) HSBC moved to hold while Bernstein upgraded to outperform. Link to article: #StocksToWatch #Investing"  
[X Link](https://x.com/investseekers/status/1994736254122901872)  2025-11-29T11:52Z 4878 followers, 3510 engagements


"The Danish C25 index closed up XXX% on Monday. Top X performers: GN Store Nord: +2.9% Maersk B: +2.6% Maersk A: +2.3% Royal Unibrew: +2.1% Coloplast: +1.5% Bottom 5: Zealand Pharma: -XXX% Ambu: -XXX% NKT: -XXX% $NVO: -XXX% Rockwool: -XXX% #Stocks #Investing"  
[X Link](https://x.com/investseekers/status/1995530168484438261)  2025-12-01T16:27Z 4875 followers, 1128 engagements


"China has added $LLY Mounjaro to its national health insurance list starting Jan X for type X diabetes. The drug is also approved in China for obesity and sleep apnea. $NVO Ozempic has been on Chinas reimbursement list since 2022 so this brings Mounjaro in line with its main competitor in the market. #StocksToWatch #Investing"  
[X Link](https://x.com/investseekers/status/1997927361803690040)  2025-12-08T07:12Z 4878 followers, 4103 engagements


"$GMAB just reported strong Phase X results for Epkinly in combination with Rituximab + Lenalidomide in follicular lymphoma. At the ASH meeting Genmab said the combo reduced the risk of disease progression or death by XX% vs Rituximab + Lenalidomide alone. In November the FDA approved this combination as a second-line treatment for relapsed or refractory follicular lymphoma. #StocksToWatch #Investing"  
[X Link](https://x.com/investseekers/status/1997959963491107124)  2025-12-08T09:22Z 4878 followers, XXX engagements


"@woodywgxonfire Never looked into it"  
[X Link](https://x.com/investseekers/status/1998045191010435223)  2025-12-08T15:01Z 4879 followers, XXX engagements


"$NVO s share price has been cut XX% since summer 2024 as obesity-growth slowed. But new calculations from Jyske Bank analyst Henrik Hallengreen show the potential upside is still huge. Base case: If Novo grows X% a year over the next decade the stock could reach XXX DKK. Bull case: With XX% annual growth successful new obesity products and strong defense vs. Lilly the share could jump to XXX DKK. Bear case: With X% growth and pressure from patent expiries the stock could fall toward XXX DKK. Henrik Hallengreen says the market has priced in a lot of negativity and still rates the stock a Buy"  
[X Link](https://x.com/investseekers/status/1990322513662906788)  2025-11-17T07:34Z 4878 followers, 8933 engagements


"$NVO reported top-line results from the evoke/evoke+ Alzheimers trials: oral semaglutide was safe but didnt slow disease progression vs placebo despite biomarker improvements. The extension phase will be discontinued. Link to announcement: #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1992918692271624661)  2025-11-24T11:30Z 4878 followers, 16.7K engagements


"Danske Bank says $NVO is now trading at 10-year low valuation multiples on a 12-month forward P/E basis. The bank reiterates a buy rating but cuts its target price to XXX DKK (from 500) after the failed Phase X Alzheimers study. Danske Bank also highlights the widening valuation gap vs. Eli Lilly which is hitting new highs while sentiment toward Novo remains very negative. #StocksToWatch #investing"  
[X Link](https://x.com/investseekers/status/1993276226559947261)  2025-11-25T11:11Z 4878 followers, 5519 engagements


"According to Jyske Bank U.S. weekly prescription data shows $NVO 's Wegovy outperforming $LLY 's Zepbound for the second week in a row. Week X (late Nov 2025): Wegovy 145000 new Rx Zepbound 128000 Wegovy +13% w/w Week X (last week): Wegovy 142000 Zepbound 135000 Wegovy ahead by X% This is the first real fight-back from Novo since Zepbound took the lead in April 2025. The GLP-1 class overall is still growing 1520% in Q4 though compounding remains a headwind. #Stocks #investment"  
[X Link](https://x.com/investseekers/status/1994357805139013813)  2025-11-28T10:48Z 4878 followers, 32.1K engagements


"The Week of $NVO: EVOKE Fallout Amycretin Surge Wegovy XXX mg Pricing Reset & Analyst Reactions EVOKE Alzheimers setback triggers global reactions Oral semaglutide did not slow Alzheimers progression vs placebo despite biomarker improvements. Jyske Bank Saxo Bank Sydbank Citi and others all stressed the same point: the odds were always low and EVOKE was a lottery ticket. Several investors and commentators called the drop overdone saying the market is reacting more to hope than probability. CEO Mike Doustdar responds publicly In a new LinkedIn video Mike Doustdar said Novo always knew the"  
[X Link](https://x.com/investseekers/status/1995212774679650573)  2025-11-30T19:26Z 4878 followers, 4639 engagements


"$AHT.L reports earnings Tuesday and its a much more interesting business than most people realise. Its one of the largest equipment rental companies in North America and the U.K. (Sunbelt Rentals) and its real edge is scale: dense branch networks clustered locations in major cities faster delivery higher availability and the ability to serve everyone from small contractors to national builders. Read my full analysis here: #StocksToWatch #investingtips"  
[X Link](https://x.com/investseekers/status/1997905227773526335)  2025-12-08T05:45Z 4878 followers, XXX engagements


"$JPM says one of Denmarks C25 stocks could nearly double in the coming months: $ZEAL. The bank lowered its price target slightly from 1050 DKK to 1000 DKK but that still implies XX% upside from Mondays opening price of XXX DKK and JPMorgan keeps an Overweight rating. Zealand Pharma which is developing multiple obesity and metabolic drugs now has one of the most bullish analyst outlooks in the sector: Highest PT: 1120 DKK (KBC Securities) Next: 1050 DKK (Jefferies) JPMorgans 1000 DKK is the third-highest among XX analysts Average PT: XXX DKK (+45% upside) Ratings: XX Buy X Hold X Sell The"  
[X Link](https://x.com/investseekers/status/1997988401128128627)  2025-12-08T11:15Z 4878 followers, XXX engagements


"$GMAB delivered a strong overall impression with its new Epkinly (epcoritamab) data over the weekend says Jyske Bank analyst Henrik Hallengreen Laustsen. Multiple studies were presented at ASH a Phase X in second-line follicular lymphoma plus Phase 1b/2 and Phase X studies in first-line FL and DLBCL. Henrik Hallengreen Laustsen says the results look solid showing Genmab has a good product that holds up well against competitors across treatment lines. Genmab shares rose XXX% to 2050 DKK on Monday helped by what Henrik Hallengreen Laustsen calls a strong overall impression and continued"  
[X Link](https://x.com/investseekers/status/1998008911509463265)  2025-12-08T12:37Z 4878 followers, 1064 engagements


"Evotec and $NVO just launched LAB eN a new drug-discovery accelerator turning academic research into real therapeutics. Why it matters: This could reshape how early drug ideas move into development. Key points: LAB eN will focus on cardiometabolic + rare endocrine/blood diseases Creates a pipeline of early-stage projects that will eventually need manufacturing partners CDMOs (contract manufacturers) may need more flexible contracts modular capacity faster scale-up and better regulatory alignment Expect growing demand for small-batch GMP work single-use bioprocessing advanced analytics and"  
[X Link](https://x.com/investseekers/status/1992192381987250211)  2025-11-22T11:24Z 4879 followers, 2555 engagements


"If I were to buy an alcohol #Stock today I would pick $REMYF Its been a rough year for spirits #stocks and Remy Cointreau now trades near a 10-year low. Yet its the force behind Rmy Martin fine champagne cognac and the ultra-premium Louis XIII. Insider ownership is huge too: the Cointreau family holds 59%. Full analysis here:"  
[X Link](https://x.com/investseekers/status/1993793132178128903)  2025-11-26T21:25Z 4878 followers, 1081 engagements


"Jyske Bank just published fresh analysis on $NVO and the firm now sets a 12-month price target of XXX DKK. Their take: Novo has faced a tough year pressure from compounders rising competition guidance cuts pricing headwinds US policy risks and CagriSema data that didnt meet expectations. Investor sentiment remains fragile and rebuilding confidence will take time as Novo works to re-accelerate growth. But Jyske Bank still sees strong long-term potential: a solid pipeline industry-leading capacity and attractive (though lower than before) growth prospects. Potential catalysts: Wegovy pill"  
[X Link](https://x.com/investseekers/status/1994799891881578521)  2025-11-29T16:05Z 4879 followers, 9933 engagements


"Jefferies cuts its price target on $NVO to XXX DKK from XXX repeating an underperform rating. The new target sits XX% below Fridays close at XXX DKK. The bank cites U.S. pricing deals for Ozempic/Wegovy and expects Ozempic volumes to stay near 600000 weekly scripts due to competition with only a small lift for Wegovy. Jefferies adds that Novo needs to broaden its portfolio to improve pricing flexibility and better position itself in the consumer market. #StocksToWatch #Investing"  
[X Link](https://x.com/investseekers/status/1995396824673198186)  2025-12-01T07:37Z 4879 followers, 3004 engagements


"Prosus repurchased another 1810829 shares at an average price of XXXXX last week. Since June XX 2022 it has bought back XX% of its shares outstanding (through Sept XX 2025). It remains my largest position ahead of $NVO. #Stocks #Investing"  
[X Link](https://x.com/investseekers/status/1995938392698224731)  2025-12-02T19:29Z 4879 followers, 2789 engagements


"Argus Research has downgraded $NVO's ADR to Hold from Buy. #stocks #investment"  
[X Link](https://x.com/investseekers/status/1998031686336979163)  2025-12-08T14:07Z 4879 followers, 3163 engagements


"A busy morning in biotech is putting pressure on $NVO and $LLY. Structure Therapeutics reported strong Phase X results for its oral weight-loss pill (up to XXXX% loss in XX weeks) while WAVE Life Sciences shared early data showing a XXX% fat reduction from a single dose. Both programs are still early but they highlight the growing pipeline of challengers aiming at the obesity market dominated by Novo and Lilly. Link to article: #stocks #Investing"  
[X Link](https://x.com/investseekers/status/1998142667507539999)  2025-12-08T21:28Z 4879 followers, 2680 engagements


"Kepler Cheuvreux says the market may be seriously undervaluing $NVO especially if oral semaglutide takes a larger share of the U.S. obesity market than expected and if CagriSema outperforms Lillys Zepbound in upcoming data. Kepler keeps its Buy rating and XXX DKK target (vs. XXX DKK close) implying 50%+ upside. They argue: Novos struggles vs. Zepbound are already fully priced in What isnt priced in: the first/leading oral obesity drug + a more competitive next-gen injectable (CagriSema) Consensus expects just XXX% U.S. market share for the pill in 2026 which Kepler calls a major underestimate"  
[X Link](https://x.com/investseekers/status/1998296136625316060)  2025-12-09T07:38Z 4879 followers, 9106 engagements


"$OXM reports earnings tonight. Oxford Industries is a major player in premium lifestyle apparel think Tommy Bahama Lilly Pulitzer and Johnny Was. With strong DTC execution pricing power loyal customers and an attractive valuation is it time to buy Full analysis here: #StocksToWatch #Investing"  
[X Link](https://x.com/investseekers/status/1998696944898658730)  2025-12-10T10:11Z 4879 followers, XXX engagements


"New data from Denmarks Patient Compensation Association shows a rising number of patients seeking compensation for NAION a rare eye condition allegedly linked to $NVO s Wegovy and Ozempic. So far XX claims have been filed and X cases decided with X patients granted compensation. NAION affects the optic nerve and can cause vision loss but remains very rare: fewer than X in 10000 users of Wegovy Ozempic or Rybelsus. #StocksToWatch #Invest"  
[X Link](https://x.com/investseekers/status/1998758475782869411)  2025-12-10T14:15Z 4879 followers, 2051 engagements


"The Danish C25 index closed up XXX% today Top X in the C25: Vestas +4.2% Maersk B +3.4% $NVO +3.3% GN Store Nord +3.2% Maersk A +2.7% Bottom 5: Pandora XXX% ISS XXX% Novonesis XXX% rsted XXX% Genmab XXX% #stocks #Investing"  
[X Link](https://x.com/investseekers/status/1998793475605803462)  2025-12-10T16:34Z 4879 followers, XXX engagements